Tokyo, Oct. 17 -- UMIN Clinical Trials Registry (UMIN-CTR) received information related to the study (UMIN000059436) titled 'Effects of lactotripeptide ingestion on muscle fatigue and recovery after resistance exercise' on Oct. 16.
Study Type:
Interventional
Study Design:
Basic Design - Cross-over
Randomization - Randomized
Blinding - Double blind -all involved are blinded
Control - Placebo
Primary Sponsor:
Institute - Waseda University
Condition:
Condition - Muscle fatigue
Classification by malignancy - Others
Genomic information - NO
Objective:
Narrative objectives1 - To examine the effect of lactotripeptide ingestion on muscle fatigue and recovery after resistance exercise
Basic objectives2 - Efficacy
Intervention:
Interventions/Control_1 - Ingestion of a test substance containing peptides
Interventions/Control_2 - Ingestion of placebo
Eligibility:
Age-lower limit - 18
years-old
=
Gender - Male and Female
Key inclusion criteria - Health young adults aged 18 to 39 years
Key exclusion criteria - Have cardiovascular disease
Smoker
A medical doctor has stopped exercise
Have lactose intolerance or milk allergy
Target Size - 25
Recruitment Status:
Recruitment status - Preinitiation
Date of protocol fixation - 2025 Year 07 Month 29 Day
Anticipated trial start date - 2025 Year 10 Month 20 Day
Last follow-up date - 2027 Year 03 Month 31 Day
To know more, visit https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000067976
Disclaimer: Curated by HT Syndication.
